TTI-621 (SIRP Fc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Anti-Tumor Activity and Minimal Erythrocyte Binding
Petrova, P. S., Viller, N. N., Wong, M., Pang, X., Lin, G. H. Y., Dodge, K., Chai, V., Chen, H., Lee, V., House, V., Vigo, N. T., Jin, D., Mutukura, T., Charbonneau, M., Truong, T., Viau, S., Johnson,Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-1700
Date:
November, 2016
File:
PDF, 1.61 MB
english, 2016